The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7) with high rate of signet cell component: Final results of the multicenter, randomized phase II/III trial of the German AIO and Italian GOIM.
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Foundation Medicine; Incyte; Lilly; MSD Oncology; Novartis; Roche; SERVIER
Speakers' Bureau - Lilly
Research Funding - AstraZeneca (Inst); Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe (Inst); Gemeinsamer Bundesausschuss; Incyte (Inst); Lilly (Inst)
 
Ralf-Dieter Hofheinz
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Lilly; medac; Merck; MSD; Pierre Fabre; Roche; Saladax Biomedical; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Lilly; Merck; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Deutsche Krebshilfe (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
 
Harald Schmalenberg
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck; MSD; Novartis
 
Dirk Strumberg
No Relationships to Disclose
 
Eray Goekkurt
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche; Sanofi
 
Stefan Angermeier
No Relationships to Disclose
 
Thomas Zander
Consulting or Advisory Role - BMS; MSD Oncology; Novartis; Pfizer; Roche
 
Jochem Potenberg
No Relationships to Disclose
 
Hans-Georg Kopp
Honoraria - BMS; Boehringer Ingelheim; Chugai Pharma; LEO Pharma; MSD Oncology; Novartis; Pfizer; PharmaMar; Roche; Sanofi/Aventis; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; PharmaMar; Roche; Sanofi
 
Daniel Pink
Speakers' Bureau - PharmaMar (Inst)
Research Funding - Bristol-Myers Squibb (Inst); EUSA Pharma (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst)
 
Gabriele Margareta Siegler
Honoraria - Aurikamed; Deutsche Röntgengesellschaft; Eisai; Janssen-Cilag; Roche
Consulting or Advisory Role - AstraZeneca; Janssen-Cilag
Research Funding - Novartis (Inst); Nutricia (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen
 
Michael Schenk
No Relationships to Disclose
 
Ferdinando De Vita
No Relationships to Disclose
 
Evaristo Maiello
No Relationships to Disclose
 
Timo Gaiser
No Relationships to Disclose
 
Disorn Sookthai
No Relationships to Disclose
 
Tanita Brulin
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Nils Homann
Consulting or Advisory Role - Amgen; BMS GmbH & Co. KG; Lilly; MSD Oncology; SERVIER
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - Institut für Klinische Krebsforschung GmbH
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; Lilly; MacroGenics; Merck Sharp & Dohme
Speakers' Bureau - AIO gGmbH; Bristol-Myers Squibb; Lilly; MCI Group
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Eurozyto; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Immutep; Ipsen; Lilly; Medac; MSD Sharp & Dohme; Roche; Sanofi; Vifor Pharma